DACA Docs Phase 1: CDDEP File Recent Data Extended Medical Files

  Big Pharma companies in India are profiteering off sick and low-income citizens by selling them experimental antibiotics that create superbugs immune to treatment. According to recent data by the Center For Disease Dynamics, Economics & Policy (CDDEP), India has the highest rates of drug-resistant bacterial infections in the world. It is also the largest consumer of antibiotics per capita.

Recent Data 2018:https://resistancemap.cddep.org/AntibioticResistance.php

Arstechnica.com reports: Now, new data paints a clearer picture as to why the country appears to be a breeding ground for drug resistant infections that threaten to spread within and beyond the country.

DAPA/DACA International Program 'UK-EU'

 DAPA/DACA International Program Extended Medical Files: http://teapartyorg.ning.com/forum/topics/dapa-daca-international-pr...

Drug companies—some international and even US-based—are selling millions of dubious and unapproved cocktails of antibiotics in India, all of which could spur the development of drug-resistant bacteria and imperil patients. The finding, published Monday in the British Journal of Clinical Pharmacology by UK health experts, suggests that the country poses a risk to global health and undermines efforts to....

The study authors, led by Patricia McGettigan of Queen Mary University of London, recommend firm regulatory action within India to ban these unapproved drug cocktails. They also call for the multinational drug companies producing some of the antibiotic mixtures—such as Abbott, GlaxoSmithKline, Astra Zeneca, Pfizer, and Merck/MSD—to be accountable for their products.

Drug companies “should be required to justify the sale of products in India that do not have the approval of their own national regulators and, in multiple cases, not even the approval of the Indian regulator,” they conclude.

Dodgy Doses UN

For the study, Prof. McGettigan and her colleagues pulled antibiotic sales figures from a commercial database of Indian drug distribution called PharmaTrac. They looked at sales between October 2007 and November 2012. They then compared the inventory of drugs sold in India to the list of drugs approved by India’s Central Drugs Standard Control Organization (CDSCO) as well as those approved by the US Food and Drug Administration (FDA) and the European Medical Agency (EMA).

The researchers found that drug companies sold 86 regular, so-called “single-dose antibiotics” and 118 “fixed-dose combination” antibiotics over the five-year period. The FDC drugs are formulations composed of two or more drugs at fixed ratios in a single dose. They can include two or more antibiotics or antibiotics and a different type of drug, such as an anti-protozoal drug. Such combo formulations are rare in the US and UK; drug companies sold just five of these in the US and UK during the same period.

Many of the 118 sold in India were “poorly considered,” the authors note. Some combined antibiotics that needed to be taken at different intervals to work. For instance, one FDC paired an antibiotic that needs to be taken once a day with another that needs to be taken every eight hours to work effectively. Some combinations risked amplified side effects while others combined drugs that wouldn’t be given to treat the same illness.

Of the 118 types of FDCs, 75 (64 percent) had no approval from either the CDSCO, FDA, or EMA. Nearly all of the single-dose antibiotics were approved, on the other hand. Still, FDCs overall made up 34 percent of antibiotics sold in India by 2012—roughly 872 million doses that year. And 42 percent of the FDCs sold contained antibiotics that the World Health Organization considered “highest-priority critically important” drugs, which should be used sparingly.

Twelve multinational companies were responsible for making 53 of the 118 types of FDCs. These included Abbott, Astra Zeneca, Baxter, Bayer, Eli Lilly, GlaxoSmithKline (GSK), Merck/MSD, Novartis, Pfizer, Sanofi-Aventis, and Wyeth. Of the 53 FDCs, only four were approved by the FDA and/or the EMA, and 20 were not approved by even India’s CDSCO. US-based Abbott, which has been criticized for its antibiotic sales in India before, sold 18 of those 20 unapproved combination drugs. In 2014, Abbott made $367 million from FDC profits in India, Reuters reported in 2015. At the time, a company spokesperson said that its manufacturing and marketing in India is “aligned with local regulations.”

The authors noted that the Indian government has made attempts to ban the unapproved drugs. But the efforts have been held up in courts, and drug regulation is weak, generally.

“The use of unapproved, scrutinized antibiotic FDC formulations is likely to contribute to India’s rising antimicrobial resistance,” the authors conclude. “Until definitive action is taken to ban most systemic antibiotic FDCs from manufacture and sale, [antimicrobial resistance] initiatives in India are likely to be undermined and the global action plan impeded.”

Views: 46

Reply to This

Replies to This Discussion

 I can see everyone is spooked, and they think they know it all about what is gong on, fancy that, DACA, and people sick, a virus, that there is no cure for. Hmmm? kind of looks like whats going on in America also.

 Its what, we are posting this stuff for amusement? Like da!!!!!

Alert: 44,116 People Have Died In America '2018'

http://teapartyorg.ning.com/forum/topics/alert-44-116-people-have-d...

We are alerting the people not the FBI or the DOJ, period, hello!!!!!!!!!!!!!

RSS

LIGHTER SIDE

 

Political Cartoons by Tom Stiglich

ALERT ALERT

 Judge Orders Mueller To Prove  Russia Meddled In Election 

Judge Dabney L. Friedrich

A Washington federal judge on Thursday ordered special counsel Robert Mueller’s team to clarify election meddling claims lodged against a Russian company operated by Yevgeny Prigozhin, an ally of Russian President Vladimir Putin, according to Bloomberg.

Concord Management and Consulting, LLC. – one of three businesses indicted by Mueller in February along with 13 individuals for election meddling, surprised the special counsel in April when they actually showed up in court to fight the charges. Mueller’s team tried to delay Concord from entering the case, arguing that thee Russian company not been properly served, however Judge Dabney Friedrich denied the request – effectively telling prosecutors ‘well, they’re here.’

Concord was accused in the indictment of supporting the Internet Research Agency (IRA), a Russian ‘troll farm’ accused of trying to influence the 2016 US election.

On Thursday, Judge Freidrich asked Mueller’s prosecutors if she should assume they aren’t accusing Concord of violating US laws applicable to election expenditures and failure to register as a foreign agent.

Concord has asked Dabney to throw out the charges – claiming that Mueller’s office fabricated a crime, and that there is no law against interfering in elections.

According to the judge’s request for clarification, the Justice Department has argued that it doesn’t have to show that Concord had a legal duty to report its expenditures to the Federal Election Commission. Rather, the allegation is that the company knowingly engaged in deceptive acts that precluded the FEC, or the Justice Department, from ascertaining whether they had broken the law. -Bloomberg

On Monday, Friedrich raised questions over whether the special counsel’s office could prove a key element of their case – saying that it was “hard to see” how allegations of Russian influence were intended to interfere with US government operations vs. simply “confusing voters,” reports law.com.

During a 90-minute hearing, Friedrich questioned prosecutor Jonathan Kravis about how the government would be able to show the Russian defendants were aware of the Justice Department and FEC’s functions and then deliberately sought to skirt them.

“You still have to show knowledge of the agencies and what they do. How do you do that?” Friedrich asked.

Kravis, a prosecutor in the U.S. Attorney’s Office for the District of Columbia, argued that the government needed only to show that Concord Management and the other defendants were generally aware that the U.S. government “regulates and monitors” foreign participation in American politics. That awareness, Kravis said, could be inferred from the Russians’ alleged creation of fake social media accounts that appeared to be run by U.S. citizens and “computer infrastructure” intended to mask the Russian origin of the influence operation.

“That is deception that is directed at a higher level,” Kravis said. Kravis appeared in court with Michael Dreeben, a top Justice Department appellate lawyer on detail to the special counsel’s office. -law.com

Concord pleaded not guilty in May. Their attorney, Eric Dubelier – a partner at Reed Smith, has described the election meddling charges as “make believe,” arguing on Monday that Mueller’s indictment against Concord “doesn’t charge a crime.”

“There is no statute of interfering with an election. There just isn’t,” said Dubelier, who added that Mueller’s office alleged a “made-up crime to fit the facts they have.”

Dubelier added that the case against Concord Management is the first in US history “where anyone has ever been charged with defrauding the Justice Department” through their failure to register under FARA.

© 2018   Created by Steve - Ning Creator.   Powered by

Badges  |  Report an Issue  |  Terms of Service